Abdul Mannan: Two Battles, One Patient – Why Women on Anticoagulants Need Better Coordinated Care
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Too many young females on anticoagulants are fighting two battles at once:
the clot… and their periods.
Our new BloodDoctor infographic highlights a problem that still flies under the radar:
Up to 60% of patients on blood thinners experience gynaecologic bleeding.
For many, it’s not just inconvenient — it leads to iron deficiency, anaemia, and in some cases, life-threatening haemorrhagic ovarian cysts.
What struck me most while creating this resource is how often these patients end up navigating it alone, without joined-up support between haematology and gynaecology.
The evidence is clear:
1. Bleeding risk varies by drug type.
Vitamin K antagonists: 22–71%
Rivaroxaban: up to 43%
2. Multidisciplinary care changes outcomes.
The safest and most effective approach brings together:
• Haematology
• Gynaecology / Adolescent Medicine
• Primary Care
• A coordinated clinic model where decisions are shared rater than made in isolation.
When these teams work together, patients avoid the unnecessary suffering created by abrupt contraceptive changes, untreated heavy bleeding, and delayed referrals.
This is a call for better collaboration, not more complexity.
- How are your teams managing gynaecologic bleeding in patients on anticoagulants?
- What has helped improve outcomes in your service?
Let’s move the conversation forward — patients deserve nothing less.”

Find more posts featuring Abdul Mannan on Hemostasis Today.
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction
-
Mar 14, 2026, 19:19Yunpeng Xue: Humbled and Honored to Receive the 2025 Eberhard F. Mammen Young Investigator Award
-
Mar 14, 2026, 19:13Abhilasha Singh: A Novel Mechanism of Cardiac Aging and Disruption of The Neurovascular Network
-
Mar 14, 2026, 19:08Saleh Owimer: The Critical Rules of Safe Blood Transfusion
-
Mar 14, 2026, 19:01Omar Adwan: Correcting Lipemic Samples in CBC Using the Plasma Replacement Method
-
Mar 14, 2026, 16:28Abdul Mannan: Advancing VWF Activity Testing Beyond VWF:RCo in Clinical Laboratories
-
Mar 14, 2026, 16:26Rida Fatima: When The Body’s Most Vital Production Unit Stops Working
-
Mar 14, 2026, 16:16Martin Haluzík: Metabolic Risk Factors and Therapeutic Opportunities in Cardiovascular Disease
-
Mar 14, 2026, 16:10Raffaella Colombatti: Proud to Have Authored the New Lancet Seminar on Sickle Cell Disease